Literature DB >> 23846207

Long-term suppression of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide.

Jeffrey H Dunn, Adriana Weinberg, Larry K Chan, Naresh Mandava, Marilyn E Levi, Jeffrey L Olson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23846207     DOI： 10.1001/jamaophthalmol.2013.1589

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  4 in total

Review 1.  Ophthalmologic Disease in HIV Infection: Recent Changes in Pathophysiology and Treatment.

Authors:  Michael W Stewart
Journal:  Curr Infect Dis Rep       Date:  2017-10-19       Impact factor: 3.725

2.  Cytomegalovirus retinitis in the post-cART era.

Authors:  Alexander D Port; Rolake O Alabi; Lisa Koenig; Mrinali P Gupta
Journal:  Curr Ophthalmol Rep       Date:  2018-05-02

3.  Donor-derived cytomegalovirus-cytotoxic T lymphocytes and leflunomide successfully control refractory cytomegalovirus infections and disease of multiple sites after allogeneic-hematopoietic stem cell transplantation: A case report.

Authors:  Nan Su; Zhenghua Liu; Peng Sun; Feng Gu; Xiaojing Yan; Dali Cai
Journal:  Front Med (Lausanne)       Date:  2022-09-06

Review 4.  Cytomegalovirus Retinitis in HIV and Non-HIV Individuals.

Authors:  Monique Munro; Tejabhiram Yadavalli; Cheryl Fonteh; Safa Arfeen; Ann-Marie Lobo-Chan
Journal:  Microorganisms       Date:  2019-12-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.